Status of bone mineral density in male patients with primary hypothyroidism


  • T.I. Krytskyi Assistant at the Department of internal medicine 1, State Institution of Higher Education “I. Horbachevsky Ternopil State Medical University”, Ternopil, Ukraine; e-mail:



hypothyroidism, bone mineral density, X-ray densitometry


Background. The issue of hypothyroidism effect on bone tissue is underinvestigated, due to the small number of studies. In addition, it’s not easy to determine the effect of reduced thyroid function on bone strength due to the fact that these patients are usually elderly and have many additional factors for the development of osteoporosis. The purpose of the study is to assess the status of bone mineral density (BMD) in men with hypothyroidism. Materials and methods. We have examined 35 men with primary hypothyroidism aged 28–69 years. Duration of disease (from the time of diagnosis and initiation of thyroid hormone replacement therapy) was 3 to 26 years. The average daily dose of levothyroxine was 125.5 ± 16.5 µg. Patients were in a state of compensation (no complaints and a normal level of thyroid­stimulating hormone on the background of hormone therapy). The control group consisted of 25 healthy, clinically euthyroid men aged 25–49 years. Results. Osteopenia of va­rying severity was detected in 11 (31.4 %), osteoporosis — in 8 (22.9 %) patients, and in the remaining 16 (45.7 %) persons, BMD was within normal limits. When comparing bone density graphs in patients of different age groups, it was found that with age, the frequency and severity of bone loss increases. Duration of disease has the most significant negative effect on the BMD in patients with hypothyroidism. Although the incidence of osteopenia in the group of patients with disease duration from 5 to 15 years is greater (55.0 %) than in persons with disease duration of more than 15 years (41.7 %), but osteoporosis is 2.5 times more likely in patients with longer duration of disease than in people with disease duration of 5–15 years. Conclusions. Violations of bone mineral density, which are manifested in the development of osteopenia and osteoporosis, are observed in 54.3 % of men with primary hypothyroi­dism. Severity of changes in bone mineral density is directly proportional to the age, duration of thyroid hormone replacement therapy and inversely proportional to the body mass index.


Download data is not yet available.


Sharma B, Prakash V, Agrawal N, Singh S. Prevalence of male osteoporosis in India. Indian J Endocrinol Metab. 2012;16:S519.

Povoroznjuk VV, Dzerovich NI, Karasevskaya TA. Bone mineral density in Ukrainian women of different age. Ann N Y Acad Sci. 2007 Nov;1119:243-52. doi: 10.1196/annals.1404.019.

Williams GR, Bassett JHD. Thyroid diseases and bone health. J Endocrinol Invest. 2018 Jan;41(1):99-109. doi: 10.1007/s40618-017-0753-4.

Bassett JH, Williams GR. Role of thyroid hormones in skeletal development and bone maintenance. Endocr Rev. 2016 Apr;37(2):135-87. doi: 10.1210/er.2015-1106.

Kravchenko VI, Postol SV. Incidence of thyroid pathology in Ukraine. Mìžnarodnij endokrinologìčnij žurnal. 2011;3(35):26-31. (in Ukrainian).

Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010 Jan;95(1):186-93. doi: 10.1210/jc.2009-1625.

Vestergaard P, Rejnmark L, Mosekilde L. Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int. 2005;77(3):139-344. doi: 10.1007/s00223-005-0068-x.

Wirth CD, Blum MR, da Costa BR, et al. Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis. Ann Intern Med. 2014 Aug 5;161(3):189-99. doi: 10.7326/M14-0125.

Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jorde R. The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromso study. Thyroid. 2008 Nov;18(11):1147-55. doi: 10.1089/thy.2008.0158.

Pankiv IV. Effect of vitamin D supplementation on insulin resistance in patients with hypothyroidism. Mìžnarodnij endokrinologìčnij žurnal. 2017;13(6):455-458. doi: 10.22141/2224-0721.13.6.2017.112892.

Tárraga López PJ, López CF, de Mora FN et al. Osteoporosis in patients with subclinical hypothyroidism treated with thyroid hormone. Clin Cases Miner Bone Metab. 2011;8(3):44-48.

Noh HM, Park YS, Lee J, Lee W. A cross-sectional study to examine the correlation between serum TSH levels and the osteoporosis of the lumbar spine in healthy women with normal thyroid function. Osteoporos Int. 2015 Mar;26(3):997-1003. doi: 10.1007/s00198-014-2906-z.

Svare A, Nilsen TI, Asvold BO, et al. Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway. Eur J Endocrinol. 2013 Oct 23;169(6):845-52. doi: 10.1530/EJE-13-0546.

Kaminskyi OV, Pankiv VI, Pankiv IV, Afanasyev DE. Vitamin D content in population of radiologically contaminated areas in Chernivtsi region (pilot project). Probl Radiac Med Radiobiol. 2018 Dec;23:442-451. doi: 10.33145/2304-8336-2018-23-442-451.



How to Cite

Krytskyi, T. (2021). Status of bone mineral density in male patients with primary hypothyroidism. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 15(4), 322–327.



Original Researches